Plain-English translation of NCT05933161 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes Mellitus research guide →This study is testing whether a standard blood sugar test (called A1C, which measures average blood sugar over 3 months) accurately reflects blood sugar control in people who have a Left Ventricular Assist Device (LVAD)—a mechanical pump that helps the heart work. Researchers will compare the A1C results to readings from a continuous glucose monitor (a small sensor worn on your skin that checks blood sugar throughout the day and night). By using the continuous monitor, they also hope to help you keep your blood sugar levels more stable and prevent dangerous low blood sugar episodes.
People with mechanical heart pumps may have unique changes in their bodies that could affect how well traditional blood sugar tests work. This trial exists to find out if doctors need different ways to monitor and manage blood sugar in these patients, so they can provide the best possible care.
You likely qualify if…
You likely don't qualify if…
You will wear a continuous glucose monitor (the Freestyle Libre 3) that sits on your skin and tracks your blood sugar automatically. You'll use a smartphone app to share your readings with the research team. You'll have visits at the start and at 3 months, where your blood will be checked for the standard A1C test. The study compares your continuous monitor readings with your A1C results to see how well they match up and whether the monitor helps you achieve better blood sugar control.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States